Tag: Cancer: Lung
Chemoradiation With SABR Boost Safe, Effective for Advanced Lung Cancer
Increased radiation with SABR boost seems to enhance local control but with reduced overall survival at highest dose
Moderate-to-Vigorous Exercise Can Delay Mortality in Inoperable Lung Cancer
However, few individuals with newly diagnosed lung cancer engage in daily moderate-to-vigorous physical activity
Study IDs Downstream Procedure, Complication Rates After Lung Cancer Screening
Complication rates substantially higher after abnormal findings with low-dose CT lung cancer screening versus those seen in National Lung Screening Trial
Study Looks at Survival in Metastatic NSCLC Treated With Immunotherapy
Survival similar among racial and ethnic groups; ECOG performance status linked to survival
10-Year Lung Cancer-Specific Survival for Low-Dose CT Persists
10-year lung cancer-specific survival of 80 percent reported in 2006 persisted, with 81 percent survival at 20 years
Osimertinib + Chemo Improves Progression-Free Survival in Advanced NSCLC
Greater incidence of grade 3 or higher adverse events from any cause seen in combination group versus monotherapy
Pembrolizumab + Standard Chemotherapy Beneficial in Mesothelioma
Improvement in overall survival seen for patients receiving cisplatin or carboplatin with pemetrexed
Rate of New Lung Cancer Cases Has Decreased Over Last Five Years
26.6 percent of people alive five years after a lung cancer diagnosis, with 22 percent improvement seen over last five years
2023 Guidelines Update Eligibility for Lung Cancer Screening
Updated guidelines recommend annual screening for those aged 50 to 80 years who currently smoke, or formerly smoked
